{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_codes_comments in Code Comments (approximate match)
Status:
Possibly Marketed Outside US
Source:
BLA125771
(2023)
Source URL:
First approved in 2023
Source:
BLA125771
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT03169660: Phase 4 Interventional Completed Exudative Age-related Macular Degeneration
(2015)
Source URL:
First approved in 2023
Source:
DR.K CELL REPAIR GENIC AMPOULE by Noblesse Korea Co., Ltd.
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
Nuwiq by Octapharma Pharmazeutika Produktionsges M B H [Canada]
Source URL:
First approved in 2015
Source:
BLA125555
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
Ontosein by Gruenenthal [W. Germany]
Source URL:
First approved in 2015
Source:
21 CFR 352
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT02552576: Phase 4 Interventional Completed Von Willebrand Disease
(2015)
Source URL:
First approved in 2009
Source:
BLA125251
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT03449342: Phase 4 Interventional Completed Congenital Bleeding Disorder
(2018)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT04269954: Phase 4 Interventional Unknown status Cerebral Venous Sinus Thrombosis
(2020)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT00220987: Phase 4 Interventional Completed Hyperglycemia
(2005)
Source URL:
Class:
PROTEIN
